Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451

AD is a progressive neurodegenerative disorder that is associated with the accumulation of two different insoluble protein aggregates, Aβ plaques and hyperphosphorylated tau. This study aimed to investigate the optimal acquisition and quantification of [18F]AV45 and [18F]AV1451 to image Aβ and tau,...

Description complète

Détails bibliographiques
Auteurs principaux:	Firouzian, A, Whittington, A, Searle, G, Koychev, I, Zamboni, G, Lovestone, S, Gunn, R
Format:	Journal article
Langue:	English
Publié:	SpringerOpen 2018

Documents similaires

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
par: Azadeh Firouzian, et autres
Publié: (2018-03-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
par: Niklas Mattsson, et autres
Publié: (2017-07-01)

An updated radiosynthesis of [18F]AV1451 for tau PET imaging
par: Andrew V. Mossine, et autres
Publié: (2017-06-01)

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
par: Richard M. Tsai, et autres
Publié: (2019-01-01)

Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data
par: Suzanne L. Baker, et autres
Publié: (2017-12-01)

Deep learning application for the classification of Alzheimer’s disease using 18F-flortaucipir (AV-1451) tau positron emission tomography
par: Sang Won Park, et autres
Publié: (2023-05-01)

Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [18F]-AV-1451 PET data
par: Christina B. Young, et autres
Publié: (2021-11-01)

Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
par: Marta Marquié, et autres
Publié: (2017-10-01)

Evaluation of the early-phase [18F]AV45 PET as an optimal surrogate of [18F]FDG PET in ageing and Alzheimer’s clinical syndrome
par: Matthieu Vanhoutte, et autres
Publié: (2021-01-01)

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer’s Disease beyond the Cortex
par: Zhengshi Yang, et autres
Publié: (2024-01-01)

Optimization of Automatic Synthesis and Separation of [18F] AV-45 and Quality Control
par: Qi-Zhou Zhang, et autres
Publié: (2022-04-01)

Automated Synthesis of 18F-AV45 for Aβ-Amyloid Imaging and its Preliminary Clinical Application
par: HUANG Zhenghai;REN Chao;ZHU Shikun;WANG Xuezhu;WU Meiqi;HUO Li
Publié: (2021-08-01)

A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer's disease.
par: Julie Ottoy, et autres
Publié: (2017-01-01)

Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography
par: Yuan Li, et autres
Publié: (2019-06-01)

PET tau and amyloid-β burden in mild Alzheimer's disease: divergent relationship with age, cognition and cerebrospinal fluid biomarkers
par: Koychev, I, et autres
Publié: (2017)

Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
par: Kuo-Lun Huang, et autres
Publié: (2013-01-01)

The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using 18F-AV45: Is Amyloid the Principal Actor in the Disease
par: Emilie Beaufils, et autres
Publié: (2014-11-01)

Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
par: Huan-Chun Lin, et autres
Publié: (2023-05-01)

In vivo imaging of tau deposition in Alzheimer’s disease using both [18F]-THK5317 and [18F]-S16: A pilot human study
par: Liping Fu, et autres
Publié: (2022-08-01)

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
par: Antoinette O’Connor, et autres
Publié: (2023-05-01)

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
par: Tessa Timmers, et autres
Publié: (2019-07-01)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
par: Edmond Teng, et autres
Publié: (2021-12-01)

First-in-human study of D6-[18F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [18F]FP-(+)-DTBZ (AV-133)
par: Ruiyue Zhao, et autres
Publié: (2024-10-01)

18F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease
par: Xiaojun Xu, et autres
Publié: (2022-02-01)

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET
par: Shannon L. Risacher, et autres
Publié: (2018-10-01)

Multicenter <sup>18</sup>F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
par: Michael Rullmann, et autres
Publié: (2022-03-01)

CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.
par: Rui Gao, et autres
Publié: (2016-01-01)

PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).
par: James S Toomey, et autres
Publié: (2012-01-01)

En kvalitativ studie av sykepleiestudenters opplevelser av nye læringsaktiviteter i kritisk vurdering av kvantitative forskningsartikler
par: Cecilie Katrine Utheim Grønvik, et autres
Publié: (2015-01-01)

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
par: Westwood, S, et autres
Publié: (2018)

Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
par: Cheng-Hsuan Li, et autres
Publié: (2021-03-01)

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.
par: Aiko Ishiki, et autres
Publié: (2015-01-01)

Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease
par: Ying Wang, et autres
Publié: (2022-02-01)

Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort
par: Matteo Tonietto, et autres
Publié: (2024-11-01)

[18F]Tosyl fluoride as a versatile [18F]fluoride source for the preparation of 18F-labeled radiopharmaceuticals
par: Dong Zhou, et autres
Publié: (2023-02-01)

Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics
par: Kocagoncu, E, et autres
Publié: (2020)

18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy
par: Michael L. Alosco, et autres
Publié: (2025-02-01)

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
par: Sarah Westwood, et autres
Publié: (2018-12-01)

TMSOTf assisted synthesis of 2'-deoxy-2'-[18F]fluoro-β-D-arabinofuranosylcytosine ([18F]FAC).
par: Kishore K Gangangari, et autres
Publié: (2018-01-01)

Optimizing the radiosynthesis of 6-[F-18]FDOPA using [F-18]Selectfluor
par: Forsback, S, et autres
Publié: (2013)